Horizon Therapeutics PLC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Horizon Therapeutics PLC with three other
companies in this sector in UNITED STATES :
Ionis Pharmaceuticals Inc
sales of $1.12 billion
of which 76%
was Ionis core),
Emergent BioSolutions, Inc.
of which 100%
was bio-sciences & bio-defense), and
United Therapeutics Corporation
of which 41%
Horizon Therapeutics PLC reported sales of $1.30 billion
December of 2019.
increase of 7.7%
versus 2018, when the company's sales were $1.21 billion.
Sales at Horizon Therapeutics PLC have increased during each of the previous five years
(and since 2014, sales have increased a total of 338%).
Sales of Orphan and Rheumatology saw an increase
11.8% in 2019, from
$831.48 million to $929.60 million.
Not all segments of Horizon Therapeutics PLC experienced an increase in sales in 2019:
sales of Inflammation fell 1.5% to $370.43 million.